Literature DB >> 15914280

All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells.

Kawin Leelawat1, Kenoki Ohuchida, Kazuhiro Mizumoto, Chulabhorn Mahidol, Masao Tanaka.   

Abstract

All-trans retinoic acid (ATRA) inhibits proliferation of cancer. However, the effects of ATRA on scattering and invasion of pancreatic cancer cells remain unknown. Also, the effects of ATRA on c-Met expression in pancreatic cancer have never been addressed so far. The effects of ATRA on a pancreatic cancer cell line, Capan-1, were determined by proliferation assay, scattering assay and invasion assay. In addition, the expression of c-Met in pancreatic cancer cell lines treated with ATRA was investigated by real-time PCR and western blotting. The growth-inhibitory effect of ATRA was found when the cells were cultured with 5 microM ATRA for 3 days. In cell scattering assay, ATRA-treated pancreatic cancer cells were found to spread out from their colonies. In invasion assay, cells treated with ATRA invaded the matrigel more than vehicle-treated cells. The expression of c-Met was up-regulated both in the mRNA and protein levels after the treatment of ATRA. The highest expression was found at 48 h after the treatment. ATRA induced scattering and invasion of pancreatic cancer cells, although it inhibited proliferation of those cells. In addition, ATRA also increased the protein level of c-Met. These findings may indicate that the use of retinoic acid as an anti-cancer therapeutic drug needs some additional treatments to control cell invasion or scattering.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15914280     DOI: 10.1016/j.canlet.2004.10.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Molecular determinants of retinoic acid sensitivity in pancreatic cancer.

Authors:  Sonal Gupta; Dipankar Pramanik; Radha Mukherjee; Nathaniel R Campbell; Sathyanarayanan Elumalai; Roeland F de Wilde; Seung-Mo Hong; Michael G Goggins; Ana De Jesus-Acosta; Daniel Laheru; Anirban Maitra
Journal:  Clin Cancer Res       Date:  2011-10-18       Impact factor: 12.531

2.  Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer.

Authors:  Jun Yu; Kenoki Ohuchida; Kazuhiro Mizumoto; Nami Ishikawa; Yasuhiro Ogura; Daisuke Yamada; Takuya Egami; Hayato Fujita; Seiji Ohashi; Eishi Nagai; Masao Tanaka
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.

Authors:  Kawin Leelawat; Surang Leelawat; Siriluck Narong; Suradej Hongeng
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

4.  Identification of pancreatic cancer invasion-related proteins by proteomic analysis.

Authors:  Naomi Walsh; Norma O'Donovan; Susan Kennedy; Michael Henry; Paula Meleady; Martin Clynes; Paul Dowling
Journal:  Proteome Sci       Date:  2009-02-14       Impact factor: 2.480

5.  Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis.

Authors:  Linying Chen; Xiao Xu; Xinxin Wen; Shenmin Xu; Long Wang; Wenxian Lu; Mingting Jiang; Jing Huang; Dayun Yang; Jichuang Wang; Min Zheng; Xiao Zhen Zhou; Kun Ping Lu; Hekun Liu
Journal:  Cancer Sci       Date:  2019-06-25       Impact factor: 6.716

6.  Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.

Authors:  Yen-Huang Cheng; En-Pei Isabel Chiang; Jia-Ning Syu; Che-Yi Chao; Hung-Yu Lin; Cheng-Chieh Lin; Mei-Due Yang; Shu-Yao Tsai; Feng-Yao Tang
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

7.  Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells.

Authors:  Alejandro García-Regalado; Miguel Vargas; Alejandro García-Carrancá; Elena Aréchaga-Ocampo; Claudia Haydée González-De la Rosa
Journal:  Mol Cancer       Date:  2013-05-21       Impact factor: 27.401

8.  Transcriptome profiling of liver of non-genetic low birth weight and long term health consequences.

Authors:  Alberto Miranda; Angela P López-Cardona; Ricardo Laguna-Barraza; Alexandra Calle; Irene López-Vidriero; Belén Pintado; Alfonso Gutiérrez-Adán
Journal:  BMC Genomics       Date:  2014-05-01       Impact factor: 3.969

9.  ATRA increases iodine uptake and inhibits the proliferation and invasiveness of human anaplastic thyroid carcinoma SW1736 cells: Involvement of β-catenin phosphorylation inhibition.

Authors:  Ling Lan; Spyros Basourakos; Dai Cui; Xuemei Zuo; Wei Deng; Lili Huo; Hailing Chen; Guoying Zhang; Lili Deng; Bingyin Shi; Yong Luo
Journal:  Oncol Lett       Date:  2017-10-19       Impact factor: 2.967

Review 10.  Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy.

Authors:  Viera Dobrotkova; Petr Chlapek; Pavel Mazanek; Jaroslav Sterba; Renata Veselska
Journal:  BMC Cancer       Date:  2018-11-01       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.